Nature Communications (Oct 2016)

Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity

  • Lauriane Galle-Treger,
  • Yuzo Suzuki,
  • Nisheel Patel,
  • Ishwarya Sankaranarayanan,
  • Jennifer L. Aron,
  • Hadi Maazi,
  • Lin Chen,
  • Omid Akbari

DOI
https://doi.org/10.1038/ncomms13202
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 13

Abstract

Read online

Airway hyperreactivity is driven by type 2 cytokines produced by ILC2 and Th2 cells. Here the authors show that an α7-nicotinic receptor agonist (GTS-21) inhibits ILC2 responses and is therapeutic against Alternaria-induced airway hyperreactivity in a humanized mouse model.